KELLERMAN DONALD J (VP, Clinical Dev & Med Affairs) sold 3.3% of their position (1.71K shares) of ZOSANO PHARMA CORP on the open market
Open‑market sale worth $1.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/7/2021ACC: 0001567619-21-011788
Officer· VP, Clinical Dev & Med Affairs
Since Jun 2019
-1.71K
Net shares
Net seller
$1.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.71K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.71K
Price / share
$0.81
Trade value
$1.38K
% of position
3.3%
6/4/2021
52.05K→50.34K
Total
Net shares
−1.71K
Net value
-$1.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/4/2021 | S · Sale | −1.71K | $0.81 | $1.38K | 3.3% | 52.05K | 50.34K |
| Total | −1.71K | -$1.38K | ||||||
Derivative Transactions0
No derivative transactions reported